QT
Quantamental Technologies’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $208K | Buy |
+1,846
| New | +$208K | 0.2% | 210 |
|
|
2023
Q2 | – | Sell |
-2,261
| Closed | -$229K | – | 588 |
|
|
2023
Q1 | $229K | Buy |
+2,261
| New | +$229K | 0.12% | 311 |
|
|
2022
Q4 | – | Sell |
-3,887
| Closed | -$413K | – | 593 |
|
|
2022
Q3 | $413K | Buy |
+3,887
| New | +$413K | 0.16% | 230 |
|
|
2022
Q1 | – | Sell |
-3,408
| Closed | -$290K | – | 501 |
|
|
2021
Q4 | $290K | Buy |
+3,408
| New | +$290K | 0.15% | 262 |
|
|
2020
Q1 | – | Sell |
-5,045
| Closed | -$542K | – | 301 |
|
|
2019
Q4 | $542K | Buy |
5,045
+1,808
| +56% | +$194K | 0.28% | 108 |
|
|
2019
Q3 | $292K | Buy |
3,237
+787
| +32% | +$71K | 0.1% | 354 |
|
|
2019
Q2 | $207K | Buy |
2,450
+292
| +14% | +$24.7K | 0.08% | 427 |
|
|
2019
Q1 | $190K | Buy |
+2,158
| New | +$190K | 0.09% | 392 |
|